Refine by
Hiv 1 Articles & Analysis
11 articles found
From a vaccine perspective, the V3 loop of the gp120 envelope protein of HIV-1 (HIV envelope variable region 3, V3) has been identified as a candidate for peptide-based vaccine design as it is a target for neutralizing antibodies.SARS-CoV-2 and Related CoronavirusesThe global COVID-19 pandemic caused by the SARS-CoV-2 virus has spurred the rapid ...
Silver nanoparticles can effectively inhibit more than 650 kinds of pathogenic bacteria, including Pseudomonas aeruginosa, Staphylococcus aureus, Escherichia coli, dermatophytes, other fungi, and even HIV-1. Not easy to develop drug resistance. Bacteria treated with silver nanoparticles basically cannot survive, which can prevent bacteria from developing drug ...
Researchers from Germany have recently developed a new technique that may be able to analyze and influence key stages of the HIV lifecycle, with the results of the study "Short- and long-range interactions in the HIV-1 5' UTR regulate genome dimerization and packaging" published in Nature Structural & Molecular Biology. ...
Therefore, the study of tRNA expression profile is of great significance for revealing the pathological mechanism of human diseases. 1. Cancer Gingold et al. found that there are significant differences in tRNA expression profiles between tumor cells and differentiated cells. ...
Why do we need new cell contenders in the CAR field? Well, different CAR immune cells have different advantages and sometimes unique challenges or limitations. So, we began our discussion of alternative CAR-cell types with CAR-NK cells due to their current standing as the most popular alternative CAR-based therapy. However, the expansion of CARs to other cell types has already begun and ...
In some cases it spreads to the nervous system and causes swelling around the brain. More than 1 million people with HIV/AIDS worldwide are affected with cryptococcal meningitis each year. ...
ByEnsia
The nanoparticles can penetrate TMZ–bl cells at concentrations as low as 1 µg/mL and can escape the lysosomal and endosomal cavities. Following delivery, the nanoparticles release active siRNA targeting the co–receptor CXCR4 for HIV–1 to achieve reduction in the targeted mRNA and protein expression. These nanoparticles are also non–toxic for the ...
For example, while governments of industrial countries have been able to hold HIV infection rates among adults under 1 percent, many developing-country governments have failed to do so and are now struggling with much higher infection rates. ...
Many HIV-1 envelope-based synthetic peptides behave as antigenic mimics of linear or conformational epitopes generated in vivo in infected subjects, meaning they can be used as immunogens for antibody induction in appropriate animal models or as antigens in Enzyme-Linked Immunosorbent Assay (ELISA). These peptides are linear or branched, single sequenced or ...
Clinical efficacy, tolerability and safety of various doses of Iodine-Lithium-α-Dextrin (ILαD) monotherapy have been evaluated in 56 HIV-infected patients enrolled in double blind uncontrolled randomised study during 48 weeks follow-up period. ILαD was administered intravenously three times over five days with intervals of 23 weeks between treatments for a total of 12 infusions ...
India has more than 5 million people infected with HIV-1 and this number is likely to increase in coming years. It is estimated that by the turn of this decade more than 10 million people would have been infected with this virus. ...